Tech Company Financing Transactions
Gliknik Funding Round
Gliknik, based in Baltimore, raised $11.5 million in investment from First In Ventures, SAISO Partners and private investors.
Transaction Overview
Company Name
Announced On
6/25/2021
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Series C
Investors
First In Ventures (Lead Investor)
Proceeds Purpose
This capital will help unlock the potential of these compounds and uniquely positions Gliknik to make a difference for patients with cancer or autoimmune disorders.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
801 West Baltimore St. 501A
Baltimore, MD 21201
USA
Baltimore, MD 21201
USA
Phone
Website
Email Address
Not Recorded
Overview
Gliknik develops therapies for patients with cancer and immune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Block
Vice President
Henrik Olsen
VP - Bus. Development
Jeffrey Herpst
Browse more venture capital transactions:
Prev: 6/25/2021: TRIPP venture capital transaction
Next: 6/25/2021: Graylog venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs